Patients at Ultra-high Risk of Psychosis Clinical Trial
Official title:
A Randomised Clinical Trial Examining Cognitive Remediation Plus Standard Treatment Versus Standard Treatment in Participants at Ultra-High Risk of Psychosis. - Effect on Cognitive Functioning, Functional Outcome and Symptomatology.
Cognitive deficits are known to be a core feature of schizophrenia and seem to become
manifest in the prodromal or Ultra-High Risk (UHR) state of psychosis. The cognitive deficits
are known to pose a critical barrier to functional recovery. Hence it is of vital importance
to find intervention strategies that can alleviate these cognitive deficits and consequently
improve daily functioning, and quality of life, as well as the prognosis for UHR-patients.
The investigators will examine whether:
- Cognitive remediation therapy will be superior to standard treatment in improving
cognitive functioning in UHR- patients (null hypothesis: No difference between the two
groups).
- Cognitive remediation therapy will be superior to standard treatment in improving
psychosocial functioning and clinical symptoms in UHR-patients (null hypothesis: No
difference between the two groups).
n/a